Cargando…
Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
Recently, the Food and Drug Administration placed a "black box" label on etanercept, and other tumor necrosis factor inhibitors used to treat childhood arthritis, warning of the risk of malignancies. The Food and Drug Administration made their decision based on a review of 48 cases of mali...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931479/ https://www.ncbi.nlm.nih.gov/pubmed/20712883 http://dx.doi.org/10.1186/1546-0096-8-23 |